Menu
Back to User profile » Prof. Dr. Emilio Clementi
Papers published by Prof. Dr. Emilio Clementi:
Response to: “Challenges in DPYD Test Implementation in Patients Treated with Fluoropyirimidines, is DPYD Genotype Arriving on Time?” [Response to Letter]
Montrasio C, Cheli S, Clementi E
Pharmacogenomics and Personalized Medicine 2024, 17:51-52
Published Date: 30 January 2024
Pharmacogenetic Practice of Anticancer Drugs: Multiple Approaches for an Accurate and Comprehensive Genotyping
Montrasio C, Cheli S, Clementi E
Pharmacogenomics and Personalized Medicine 2023, 16:739-746
Published Date: 27 July 2023
Seriousness, preventability, and burden impact of reported adverse drug reactions in Lombardy emergency departments: a retrospective 2-year characterization
Perrone V, Conti V, Venegoni M, Scotto S, Degli Esposti L, Sangiorgi D, Prestini L, Radice S, Clementi E, Vighi G
ClinicoEconomics and Outcomes Research 2014, 6:505-514
Published Date: 3 December 2014
Adherence and resource use among patients treated with biologic drugs: findings from BEETLE study
Degli Esposti L, Sangiorgi D, Perrone V, Radice S, Clementi E, Perone F, Buda S
ClinicoEconomics and Outcomes Research 2014, 6:401-407
Published Date: 18 September 2014
Impact of therapeutic drug monitoring of antiretroviral drugs in routine clinical management of patients infected with human immunodeficiency virus and related health care costs: a real-life study in a large cohort of patients
Perrone V, Cattaneo D, Radice S, Sangiorgi D, Federici AB, Gismondo MR, Medaglia M, Micheli V, Vimercati S, Pallone E, Degli Esposti L, Clementi E
ClinicoEconomics and Outcomes Research 2014, 6:341-348
Published Date: 14 July 2014
Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies: evidence from Phase I studies in healthy volunteers
Cossu MV, Cattaneo D, Fucile S, Pellegrino P, Baldelli S, Cozzi V, Capetti A, Clementi E
Drug Design, Development and Therapy 2014, 8:411-419
Published Date: 2 May 2014